Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004850443 | SCV005473565 | uncertain significance | not specified | 2024-08-19 | criteria provided, single submitter | clinical testing | The c.3940G>A (p.E1314K) alteration is located in exon 29 (coding exon 28) of the PIK3C2G gene. This alteration results from a G to A substitution at nucleotide position 3940, causing the glutamic acid (E) at amino acid position 1314 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |